https://doi.org/10.4081/hmr.v2i7.422

High-dose therapy. Experience of the non-Hodgkin’s lymphoma Co-operative Study Group (NHLCSG)

Vol. 2 No. 7: New Insights in Hematology, Venice (Italy), May 14-17, 2006
Published: June 8, 2009
Abstract Views: 122
PDF: 110
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

G Santini
support@pagepress.org
In aggressive, advanced stage non-Hodgkin’s lymphoma (NHL), 2nd and 3rd generation regimens gave results similar to those observed with CHOP therapy with a CR of approximately 50%, a 3-year survival probability of approximately 50% and a PFS of 35-40%. In order to improve outcome of these patients we started the 1st our study on the use of high-dose therapy as front-line therapy.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Santini, G. (2009). High-dose therapy. Experience of the non-Hodgkin’s lymphoma Co-operative Study Group (NHLCSG). Hematology Meeting Reports (formerly Haematologica Reports), 2(7). https://doi.org/10.4081/hmr.v2i7.422
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).